A recent RCT in CKD patients with SHPT treated with extended-release calcifediol (ERC) reported that adjunctive active vitamin D further reduced PTH levels by 35% but caused hypercalcemia and impaired kidney function [62]. The gene discussed is PTH; the disease is hypercalcemia disease.